Stocks · Healthcare · Medical - Specialties
908 Devices Inc. MASS
$12.69 +1.44% Close, Oct 2, 2026 · NASDAQ · Market cap $520.6M
Strong trend
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -46.0% from -122.0% a year earlier.
- The stock is in an uptrend: above its 200-day average for 53 trading days, with the 50-day average above the 200-day.
- The company holds net cash of $58.7M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 39%
- Revenue growth, 3-year CAGRBottom 41%
- Revenue growth accelerationTop 25%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 49%
- Gross marginBottom 34%
- Operating marginBottom 36%
- Accruals (lower is better)Top 16%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 49%
- Free-cash-flow yieldTop 35%
- EBITDA / enterprise valueBottom 46%
- Sales / enterprise valueBottom 37%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 45%
- 6-month returnTop 9%
- 1-year return vs S&P 500Top 30%
- Distance from 52-week highTop 2%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 14%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 8%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 46%
- Maximum drawdown, 3 yearsBottom 25%
- Beta vs S&P 500 (lower is better)Bottom 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.2% | 4.6% | ↑ |
| Gross margin | 49.6% | 49.8% | ↑ |
| Operating margin | -122.0% | -46.0% | ↑ |
| FCF margin | -50.4% | 0.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.6% | 2.2% | ↑ | Bottom 39% |
| Gross margin | 49.8% | 49.6% | ↑ | Bottom 34% |
| Operating margin | -46.0% | -122.0% | ↑ | Bottom 36% |
| Net margin | -56.7% | -31.7% | ↓ | — |
| Free-cash-flow margin | 0.8% | -50.4% | ↑ | — |
| Return on invested capital | -18.7% | — | Top 49% | |
| Revenue growth, 3-year CAGR | 6.2% | — | Bottom 41% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -18.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 16.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +84.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.33%
- Shareholder yield
- -0.33%
- Share count change, 1 year
- +5.2%
- Share count change, 3-year CAGR
- +5.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -46.4%
- Average 2-day reaction, last 8
- +8.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $12.00
- Target vs current price
- -5.4%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 11, 2026 | -125.4% | +13.7% | +15.8% | +11.5% | — |
| May 6, 2026 | -46.7% | +13.7% | +7.9% | +22.1% | +13.0% |
| Mar 3, 2026 | +16.7% | -4.4% | -3.6% | -13.0% | +23.4% |
| Nov 10, 2025 | -30.4% | -13.3% | -25.7% | -9.5% | -16.0% |
| Aug 5, 2025 | -125.0% | -2.8% | -1.4% | -8.9% | +22.5% |
| May 13, 2025 | +18.5% | -18.8% | -16.8% | +23.9% | +12.0% |
| Mar 4, 2025 | -60.0% | +96.0% | +52.5% | +126.3% | +201.0% |
| Nov 12, 2024 | +20.7% | -19.3% | -34.8% | -33.4% | -33.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.32 | -$0.14 | -125.4% | $16.1M |
| May 6, 2026 | -$0.22 | -$0.15 | -46.7% | $13.4M |
| Mar 3, 2026 | -$0.05 | -$0.06 | +16.7% | $17.4M |
| Nov 10, 2025 | -$0.15 | -$0.12 | -30.4% | $14.0M |
| Aug 5, 2025 | -$0.36 | -$0.16 | -125.0% | $13.0M |
| May 13, 2025 | -$0.22 | -$0.27 | +18.5% | $11.8M |
| Mar 4, 2025 | -$0.56 | -$0.35 | -60.0% | $18.8M |
| Nov 12, 2024 | -$0.23 | -$0.29 | +20.7% | $16.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 7.59× | — | — | Bottom 37% |
| Free-cash-flow yield | 0.09% | — | — | Top 35% |
| Earnings yield | -7.49% | — | — | Top 49% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 44
- Days above the 200-day average
- 53
- 50-day average slope (20 days)
- +12.5%
- 200-day average slope (20 days)
- +6.4%
- Distance from 50-day average
- +26.9%
- Distance from 200-day average
- +64.3%
- RSI (14)
- 74.2
- Relative volume
- 1.12×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 57.9%
- Volatility vs own 5-year history
- 9th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.19
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- +0.0%
- Maximum drawdown, 3 years
- -84.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | Dec 18, 2024 | -97.5% | 967 days | Not yet recovered |
| Dec 24, 2020 | Jan 8, 2021 | -22.1% | 9 days | 18 days (Feb 4, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $520.6M
- EPS, diluted (TTM)
- -$0.95
- Revenue (TTM)
- $60.8M
- 52-week range
- $5.03 – $12.93
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $42.2M | $46.9M | $50.2M | $59.6M | $56.2M |
| Gross profit | $23.2M | $26.0M | $25.3M | $29.9M | $26.8M |
| Operating income | -$22.1M | -$35.4M | -$42.8M | -$76.7M | -$24.2M |
| Net income | -$22.2M | -$33.6M | -$36.4M | -$72.2M | -$36.6M |
| EPS (diluted) | -$0.79 | -$1.07 | -$1.13 | -$2.12 | -$0.94 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.5M | $18.8M | $11.8M | $13.0M | $14.0M | $17.4M | $13.4M | $16.1M |
| Net income | -$29.3M | -$19.4M | $43.6M | -$13.3M | -$14.9M | $4.3M | -$12.0M | -$11.9M |
| EPS (diluted) | -$0.68 | -$0.57 | $1.23 | -$0.37 | -$0.41 | $0.10 | -$0.32 | -$0.32 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$29.1M | -$20.9M | -$25.1M | -$30.2M | -$23.7M |
| Capital expenditure | -$737,000 | -$2.0M | -$2.0M | -$602,000 | -$955,000 |
| Free cash flow | -$29.8M | -$23.0M | -$27.1M | -$30.8M | -$24.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $852,000 | $1.6M | $936,000 | $1.1M | $864,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $101.5M
- Total assets
- $197.5M
- Total liabilities
- $70.8M
- Total debt
- $4.3M
- Net debt
- -$58.7M
- Shareholders’ equity
- $126.8M
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 2,746,771
- Days to cover
- 9.29
- Change vs previous report
- -2.2%
FINRA short interest, settlement date Sep 15, 2026.